{"id":"https://openalex.org/A5069578183","orcid":null,"observed_orcids":[],"display_name":"Todd M. Baughman","raw_author_names":["Baughman, Todd M.","T M Baughman","T.M. Baughman","Todd Baughman","Todd M. Baughman"],"full_name":"Baughman, Todd M.","works_count":14,"cited_by_count":748,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":11,"i10_index":12},"ids":{"openalex":"https://openalex.org/A5069578183","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I168537998","ror":"https://ror.org/01qat3289","display_name":"Eli Lilly (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},"years":[1997]},{"institution":{"id":"https://openalex.org/I19648265","ror":"https://ror.org/04qk6pt94","display_name":"Wright State University","country_code":"US","type":"education","lineage":["https://openalex.org/I19648265"]},"years":[1995]},{"institution":{"id":"https://openalex.org/I4210114143","ror":"https://ror.org/025vn3989","display_name":"GlaxoSmithKline (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},"years":[2014,2013,2009,2007,2005,2003]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":9,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":5,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","count":2,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","count":2,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","count":2,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":2.09e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":1.93e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","value":1.32e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","value":8.9e-06,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":8e-06,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.941735029220581},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.7554346323013306},{"id":"202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","score":0.6046355962753296},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.4151343107223511},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.37610694766044617}],"counts_by_year":[{"year":1995,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1996,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1997,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1998,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2003,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2004,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2005,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2007,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2009,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":31},{"year":2013,"works_count":1,"oa_works_count":0,"cited_by_count":33},{"year":2014,"works_count":3,"oa_works_count":2,"cited_by_count":30},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":29},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":18},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":29},{"year":2018,"works_count":1,"oa_works_count":0,"cited_by_count":21},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":19},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":15},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":16},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":16},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":23},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":9}],"display_name_alternatives":["Baughman, Todd M.","T M Baughman","T.M. Baughman","Todd Baughman","Todd M. Baughman"],"block_key":"t baughman","works_api_url":"https://api.openalex.org/works?filter=author.id:A5069578183","updated_date":"2026-11-07T12:08:38","created_date":"2016-06-24T00:00:00"}